These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16998297)

  • 61. [Peripheral polyneuropathy and bilateral optic neuropathy during treatment of chronic hepatitis C].
    Chrissafidou A; Musch E
    Dtsch Med Wochenschr; 2009 Apr; 134(18):927-30. PubMed ID: 19384811
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Side effects of the combined antiviral therapy in patients with chronic hepatitis C].
    Vashakidze ET; Gegeshidze TN; Zhamutashvili MT; Svanidze MB
    Georgian Med News; 2007; (148-149):26-8. PubMed ID: 17921538
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Vitiligo associated with pegylated interferon and ribavirin treatment of patients with chronic hepatitis C: a case report.
    Tomasiewicz K; Modrzewska R; Semczuk G
    Adv Ther; 2006; 23(1):139-42. PubMed ID: 16644614
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bell's palsy during interferon therapy for chronic hepatitis C infection in patients with haemorrhagic disorders.
    Ogundipe O; Smith M
    Haemophilia; 2000 Mar; 6(2):110-2. PubMed ID: 10781198
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tolerability of Peg interferon-alpha2b and Ribavirin therapy in patients with chronic hepatitis C and glucose-6-phosphate dehydrogenase deficiency.
    Demelia L; Civolani A; Murgia D; Murru A; Sorbello O; Rizzetto M
    J Hepatol; 2007 Jan; 46(1):171-3. PubMed ID: 17107736
    [No Abstract]   [Full Text] [Related]  

  • 66. Factor VIII and IX deficiencies related to acquired inhibitors in a patient with chronic hepatitis C virus infection receiving treatment with pegylated interferon plus ribavirin.
    Campos-de-Magalhães M; Eduardo Brandão-Mello C; Lúcia Elias Pires M; Cecília da Fonseca Salgado M; Barcelo de Brito S; José de Almeida A
    Hematology; 2011 Mar; 16(2):80-5. PubMed ID: 21418737
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Lateral rectus muscle paralysis induced by ribavirin and pegylated interferon-α2a in a patient with HIV/HCV co-infection.
    Mellon G; Stitou H; Aoun O; Tubiana R; Thibault V; Valantin MA; Bricaire F
    J Infect Chemother; 2012 Dec; 18(6):937-8. PubMed ID: 22350324
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Severe stomatitis complicating treatment with pegylated-interferon alpha-2a and ribavirin in an HCV-infected patient.
    Borrás-Blasco J; Primo J; Rosique-Robles JD; Casterá E; Abad FJ; Jiménez I
    South Med J; 2008 Jan; 101(1):88-90. PubMed ID: 18176299
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Treatment of autoimmune thrombocytopenia in a case of chronic hepatitis C with ursodeoxycholic acid.
    Naz H; Aslan V
    J Infect Dev Ctries; 2009 Sep; 3(8):644-6. PubMed ID: 19801810
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Reversible sudden hearing loss in a chronic hepatitis C patient who achieved a sustained response to antiviral re-treatment.
    Zampino R; Costa G; Barillari M; Adinolfi LE; Marrone A
    Infez Med; 2012 Jun; 20(2):117-9. PubMed ID: 22767311
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Acute allograft rejection following interferon therapy for hepatitis C in recipients who have returned to dialysis after kidney transplant failure: case study.
    Fabrizi F; D'Ambrosio R; Pallotti F; Berardinelli L; Messa P; Martin P; Aghemo A
    Int J Artif Organs; 2014 Nov; 37(11):803-8. PubMed ID: 25362901
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pegylated-interferon-α(2a) in clinical practice: how to manage patients suffering from side effects.
    Calvaruso V; Mazza M; Almasio PL
    Expert Opin Drug Saf; 2011 May; 10(3):429-35. PubMed ID: 21323500
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pleural effusion associated with pegylated interferon alpha and ribavirin treatment for chronic hepatitis C.
    Arora A; Vargas L; Kuzniar TJ
    J Hosp Med; 2009 Sep; 4(7):E45-6. PubMed ID: 19753589
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Acquired hemophilia A in a patient with chronic hepatitis C virus infection receiving treatment with peginterferon α-2a].
    Martínez Pascual C; Antón Ródenas G; Ortiz Sánchez ML; Pons Miñano JA
    Med Clin (Barc); 2013 Sep; 141(5):228-9. PubMed ID: 23473306
    [No Abstract]   [Full Text] [Related]  

  • 75. Side effects of antiviral therapy in hepatitis C virus infection-sarcoidosis - case report.
    Teodor D; Teodor A; Grigore L; Jugănariu G; Dorobăţ CM; Miftode E; Azoicăi D
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1039-43. PubMed ID: 23700885
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Pulmonary embolism in a 30 year-old man with chronic hepatitis C during therapy with pegylated interferon-α and ribavirin].
    Elikowski W; Małek M; Kurosz J; Bereszyńska I; Marszałek A; Zawilska K; Mozer-Lisewska I
    Kardiol Pol; 2010 Nov; 68(11):1261-5. PubMed ID: 21108207
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon alpha 2a therapy for chronic hepatitis C virus infection.
    Khiani V; Kelly T; Shibli A; Jensen D; Mohanty SR
    World J Gastroenterol; 2008 Jan; 14(2):318-21. PubMed ID: 18186575
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Tubo-ovarian abscess during therapy of chronic hepatitis C with pegylated interferon and ribavirin.
    Inglot M; Szymczak A; Fleischer-Stepniewska K; Fleischer M; Staszek-Zurowska B; Gladysz A
    Neuro Endocrinol Lett; 2011; 32(1):1-3. PubMed ID: 21407153
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Chronic cough associated with interferon/ribavirin therapy for hepatitis C.
    Dicpinigaitis PV; Weiner FR
    J Clin Pharm Ther; 2011 Jun; 36(3):416-8. PubMed ID: 21545621
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Recovery after L-DOPA treatment in peginterferon and ribavirin induced parkinsonism.
    Bersano A; Aghemo A; Rumi MG; Ballabio E; Candelise L; Colombo M
    Eur J Intern Med; 2008 Jul; 19(5):370-1. PubMed ID: 18549943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.